URINARY-EXCRETION OF VALPROATE AND SOME METABOLITES IN CHRONICALLY TREATED PATIENTS

被引：68

作者：

DICKINSON, RG ^{[1
]}

HOOPER, WD ^{[1
]}

DUNSTAN, PR ^{[1
]}

EADIE, MJ ^{[1
]}

机构：

[1] UNIV QUEENSLAND,DEPT MED,NEUROPHARMACOL & DRUG METAB LAB,BRISBANE,QLD 4000,AUSTRALIA

来源：

THERAPEUTIC DRUG MONITORING | 1989年 / 11卷 / 02期

关键词：

D O I：

10.1097/00007691-198903000-00002

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：127 / 133

页数：7

共 17 条

[1] THE EFFECT OF ASPIRIN ON VALPROIC ACID METABOLISM [J].

ABBOTT, FS ;

KASSAM, J ;

ORR, JM ;

FARRELL, K .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (01) :94-100

[2] MECHANISM OF ANTI-CONVULSANT ACTION OF VALPROATE [J].

CHAPMAN, A ;

KEANE, PE ;

MELDRUM, BS ;

SIMIAND, J ;

VERNIERES, JC .

PROGRESS IN NEUROBIOLOGY, 1982, 19 (04) :315-359

[3]

DICKINSON RG, 1979, J PHARMACOL EXP THER, V211, P583

[4]

DICKINSON RG, 1980, J PHARMACOL EXP THER, V213, P38

[5] REARRANGEMENT OF VALPROATE GLUCURONIDE IN A PATIENT WITH DRUG-ASSOCIATED HEPATOBILIARY AND RENAL DYSFUNCTION [J].

DICKINSON, RG ;

KLUCK, RM ;

HOOPER, WD ;

PATTERSON, M ;

CHALK, JB ;

EADIE, MJ .

EPILEPSIA, 1985, 26 (06) :589-593

[6] VALPROATE-ASSOCIATED HEPATOTOXICITY AND ITS BIOCHEMICAL-MECHANISMS [J].

EADIE, MJ ;

HOOPER, WD ;

DICKINSON, RG .

MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1988, 3 (02) :85-106

[7] IDENTIFICATION OF URINARY METABOLITES OF SODIUM DIPROPYLACETATE IN MAN - POTENTIAL SOURCES OF INTERFERENCE IN ORGANIC-ACID SCREENING PROCEDURES [J].

GOMPERTZ, D ;

TIPPETT, P ;

BARTLETT, K ;

BAILLIE, T .

CLINICA CHIMICA ACTA, 1977, 74 (02) :153-160

[8] ASPECTS OF THE METABOLISM OF VALPROIC ACID [J].

GRANNEMAN, GR ;

WANG, SI ;

MACHINIST, JM ;

KESTERSON, JW .

XENOBIOTICA, 1984, 14 (05) :375-387

[9]

GRANNEMAN GR, 1984, METABOLISM ANTIEPILE, P97

[10] CLINICAL PHARMACOKINETICS OF VALPROIC ACID [J].

GUGLER, R ;

UNRUH, GEV .

CLINICAL PHARMACOKINETICS, 1980, 5 (01) :67-83

← 1 2 →